Literature DB >> 18088131

Synthesis of water-soluble dendrimers based on melamine bearing 16 paclitaxel groups.

Jongdoo Lim1, Eric E Simanek.   

Abstract

The design, synthesis, and characterization of triazine dendrimers derivatized with the anticancer agent paclitaxel are described. The precursor generation two dendrimer 1 is prepared in six linear steps in 64% overall yield and presents 16 amines and two groups for radioiodination. This macromolecule is subsequently derivatized with a paclitaxel conjugate to yield a generation three dendrimer, 2, which is then pegylated in two steps. The pegylated final products, 4a and 4b, with molecular weights of 46 and 77 kDa, respectively, solubilize paclitaxel in water. Pegylated dendrimer 4a is 30 wt % paclitaxel, 52 wt % PEG, and 18 wt % dendrimer. Target 4b is 18 wt % paclitaxel, 71 wt % PEG, and 11 wt % dendrimer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18088131     DOI: 10.1021/ol7024907

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  18 in total

1.  Chemotherapeutic evaluation of a synthetic tubulysin analogue-dendrimer conjugate in c26 tumor bearing mice.

Authors:  William C Floyd; Gopal K Datta; Shinichi Imamura; Heidi M Kieler-Ferguson; Katherine Jerger; Andrew W Patterson; Megan E Fox; Francis C Szoka; Jean M J Fréchet; Jonathan A Ellman
Journal:  ChemMedChem       Date:  2011-01-03       Impact factor: 3.466

2.  Design, synthesis, and biological evaluation of a robust, biodegradable dendrimer.

Authors:  Derek G van der Poll; Heidi M Kieler-Ferguson; William C Floyd; Steven J Guillaudeu; Katherine Jerger; Francis C Szoka; Jean M Fréchet
Journal:  Bioconjug Chem       Date:  2010-04-21       Impact factor: 4.774

3.  Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct.

Authors:  Su-Tang Lo; Stephan Stern; Jeffrey D Clogston; Jiwen Zheng; Pavan P Adiseshaiah; Marina Dobrovolskaia; Jongdoo Lim; Anil K Patri; Xiankai Sun; Eric E Simanek
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

4.  Synthesis and characterization of a triazine dendrimer that sequesters iron(III) using 12 desferrioxamine B groups.

Authors:  Jongdoo Lim; Vincent J Venditto; Eric E Simanek
Journal:  Bioorg Med Chem       Date:  2010-05-20       Impact factor: 3.641

5.  Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.

Authors:  Larisa Sheihet; Olga B Garbuzenko; Jared Bushman; Murugesan K Gounder; Tamara Minko; Joachim Kohn
Journal:  Eur J Pharm Sci       Date:  2011-12-03       Impact factor: 4.384

6.  Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications.

Authors:  Raghavendra S Navath; Anupa R Menjoge; Bing Wang; Roberto Romero; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Biomacromolecules       Date:  2010-06-14       Impact factor: 6.988

7.  SYNTHESIS OF 2-[3,3'-DI-(TERT-BUTOXYCARBONYL)-AMINODIPROPYLAMINE]-4,6,-DICHLORO-1,3,5-TRIAZINE AS A MONOMER AND 1,3,5-[TRIS-PIPERAZINE]-TRIAZINE AS A CORE FOR THE LARGE SCALE SYNTHESIS OF MELAMINE (TRIAZINE) DENDRIMERS.

Authors:  Abdellatif Chouai; Vincent J Venditto; Eric E Simanek; Ruth E McDermott; John A Ragan
Journal:  Organic Synth       Date:  2009-01-01

8.  Dendrimers terminated with dichlorotriazine groups provide a route to compositional diversity.

Authors:  Subrata Patra; Brittany Kozura; Adela Y-T Huang; Alan E Enciso; Xiankai Sun; Jer-Tsong Hsieh; Chai-Lin Kao; Hui-Ting Chen; Eric E Simanek
Journal:  Org Lett       Date:  2013-07-19       Impact factor: 6.005

9.  Intercepting the synthesis of triazine dendrimers with nucleophilic pharmacophores: a general strategy toward drug delivery vehicles.

Authors:  Vincent J Venditto; Kimberly Allred; Clinton D Allred; Eric E Simanek
Journal:  Chem Commun (Camb)       Date:  2009-08-11       Impact factor: 6.222

Review 10.  A critical review of lipid-based nanoparticles for taxane delivery.

Authors:  Lan Feng; Russell J Mumper
Journal:  Cancer Lett       Date:  2012-07-13       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.